These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 35607951)
1. Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19. Rocheleau GLY; Lee T; Mohammed Y; Goodlett D; Burns K; Cheng MP; Tran K; Sweet D; Marshall J; Slutsky AS; Murthy S; Singer J; Patrick DM; Du B; Peng Z; Lee TC; Boyd JH; Walley KR; Lamontagne F; Fowler R; Winston BW; Haljan G; Vinh DC; McGeer A; Maslove D; Patrigeon SP; Mann P; Donohoe K; Hernandez G; Russell JA; Crit Care Med; 2022 Sep; 50(9):1306-1317. PubMed ID: 35607951 [TBL] [Abstract][Full Text] [Related]
2. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. ; Lawler PR; Derde LPG; van de Veerdonk FL; McVerry BJ; Huang DT; Berry LR; Lorenzi E; van Kimmenade R; Gommans F; Vaduganathan M; Leaf DE; Baron RM; Kim EY; Frankfurter C; Epelman S; Kwan Y; Grieve R; O'Neill S; Sadique Z; Puskarich M; Marshall JC; Higgins AM; Mouncey PR; Rowan KM; Al-Beidh F; Annane D; Arabi YM; Au C; Beane A; van Bentum-Puijk W; Bonten MJM; Bradbury CA; Brunkhorst FM; Burrell A; Buzgau A; Buxton M; Cecconi M; Cheng AC; Cove M; Detry MA; Estcourt LJ; Ezekowitz J; Fitzgerald M; Gattas D; Godoy LC; Goossens H; Haniffa R; Harrison DA; Hills T; Horvat CM; Ichihara N; Lamontagne F; Linstrum KM; McAuley DF; McGlothlin A; McGuinness SP; McQuilten Z; Murthy S; Nichol AD; Owen DRJ; Parke RL; Parker JC; Pollock KM; Reyes LF; Saito H; Santos MS; Saunders CT; Seymour CW; Shankar-Hari M; Singh V; Turgeon AF; Turner AM; Zarychanski R; Green C; Lewis RJ; Angus DC; Berry S; Gordon AC; McArthur CJ; Webb SA JAMA; 2023 Apr; 329(14):1183-1196. PubMed ID: 37039790 [TBL] [Abstract][Full Text] [Related]
3. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study. Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166 [TBL] [Abstract][Full Text] [Related]
4. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911 [TBL] [Abstract][Full Text] [Related]
5. [Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the Zuraeva ZT; Vikulova OK; Malysheva NM; Nikankina LV; Zaytceva NV; Sukhareva OY; Shamhalova MS; Shestakova MV; Mokrysheva NG Probl Endokrinol (Mosk); 2023 Aug; 69(4):21-31. PubMed ID: 37694864 [TBL] [Abstract][Full Text] [Related]
6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
7. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials. Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926 [TBL] [Abstract][Full Text] [Related]
8. Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study. Christiansen CF; Heide-Jørgensen U; Rasmussen TB; Bodilsen J; Søgaard OS; Maeng M; Vistisen ST; Schmidt M; Pottegård A; Lund LC; Reilev M; Hallas J; Johansen NB; Brun NC; Sørensen HT; Thomsen RW J Am Heart Assoc; 2020 Oct; 9(19):e017297. PubMed ID: 32998607 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. Shukla AK; Banerjee M High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533 [TBL] [Abstract][Full Text] [Related]
10. Timing matters in the use of renin-angiotensin system modulators and COVID-related cognitive and cerebrovascular dysfunction. Meier M; Becker S; Levine E; DuFresne O; Foster K; Moore J; Burnett FN; Hermanns VC; Heath SP; Abdelsaid M; Coucha M PLoS One; 2024; 19(7):e0304135. PubMed ID: 39074114 [TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care. Haroon S; Subramanian A; Cooper J; Anand A; Gokhale K; Byne N; Dhalla S; Acosta-Mena D; Taverner T; Okoth K; Wang J; Chandan JS; Sainsbury C; Zemedikun DT; Thomas GN; Parekh D; Marshall T; Sapey E; Adderley NJ; Nirantharakumar K BMC Infect Dis; 2021 Mar; 21(1):262. PubMed ID: 33722197 [TBL] [Abstract][Full Text] [Related]
12. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI. Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974 [TBL] [Abstract][Full Text] [Related]
13. Adverse impact of renin-angiotensin system blockade on the clinical course in hospitalized patients with severe COVID-19: a retrospective cohort study. Lim JH; Cho JH; Jeon Y; Kim JH; Lee GY; Jeon S; Noh HW; Lee YH; Lee J; Chang HH; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Kim SW Sci Rep; 2020 Nov; 10(1):20250. PubMed ID: 33219294 [TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes. Silva MG; Falcoff NL; Corradi GR; Alfie J; Seguel RF; Tabaj GC; Iglesias LI; Nuñez M; Guman GR; Gironacci MM Life Sci; 2022 Mar; 293():120324. PubMed ID: 35032553 [TBL] [Abstract][Full Text] [Related]
15. Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review and Meta-Analysis. Chan CK; Huang YS; Liao HW; Tsai IJ; Sun CY; Pan HC; Chueh JS; Wang JT; Wu VC; Chu TS; Hypertension; 2020 Nov; 76(5):1563-1571. PubMed ID: 32869673 [TBL] [Abstract][Full Text] [Related]
16. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. Mancia G; Rea F; Ludergnani M; Apolone G; Corrao G N Engl J Med; 2020 Jun; 382(25):2431-2440. PubMed ID: 32356627 [TBL] [Abstract][Full Text] [Related]
17. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19. Matsuzawa Y; Kimura K; Ogawa H; Tamura K Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498 [TBL] [Abstract][Full Text] [Related]
18. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565 [TBL] [Abstract][Full Text] [Related]
19. Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019. Oddy C; Allington J; McCaul J; Keeling P; Senn D; Soni N; Morrison H; Mawella R; Samuel T; Dixon J Clin Ther; 2021 Apr; 43(4):e97-e110. PubMed ID: 33712270 [TBL] [Abstract][Full Text] [Related]
20. The concern about ACE/ARB and COVID-19: Time to hold your horses! Pergolizzi JV; Varrassi G; Magnusson P; LeQuang JA; Leopoulou M; Paladini A; Taylor R; Wollmuth C; Breve F; J Am Pharm Assoc (2003); 2020; 60(6):e88-e90. PubMed ID: 32747165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]